NM_198129.4:c.160C>T

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4_ModerateBP6_ModerateBP7

The NM_198129.4(LAMA3):​c.160C>T​(p.Leu54Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000901 in 1,553,776 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).

Frequency

Genomes: 𝑓 0.00058 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000036 ( 0 hom. )

Consequence

LAMA3
NM_198129.4 synonymous

Scores

1
1

Clinical Significance

Likely benign criteria provided, single submitter B:2

Conservation

PhyloP100: 2.36

Publications

0 publications found
Variant links:
Genes affected
LAMA3 (HGNC:6483): (laminin subunit alpha 3) The protein encoded by this gene belongs to the laminin family of secreted molecules. Laminins are heterotrimeric molecules that consist of alpha, beta, and gamma subunits that assemble through a coiled-coil domain. Laminins are essential for formation and function of the basement membrane and have additional functions in regulating cell migration and mechanical signal transduction. This gene encodes an alpha subunit and is responsive to several epithelial-mesenchymal regulators including keratinocyte growth factor, epidermal growth factor and insulin-like growth factor. Mutations in this gene have been identified as the cause of Herlitz type junctional epidermolysis bullosa and laryngoonychocutaneous syndrome. Alternative splicing and alternative promoter usage result in multiple transcript variants. [provided by RefSeq, Dec 2014]
LAMA3 Gene-Disease associations (from GenCC):
  • junctional epidermolysis bullosa
    Inheritance: AR Classification: DEFINITIVE Submitted by: Myriad Women’s Health
  • laryngo-onycho-cutaneous syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp
  • junctional epidermolysis bullosa Herlitz type
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet
  • junctional epidermolysis bullosa, non-Herlitz type
    Inheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
  • generalized junctional epidermolysis bullosa non-Herlitz type
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.29).
BP6
Variant 18-23689843-C-T is Benign according to our data. Variant chr18-23689843-C-T is described in ClinVar as Likely_benign. ClinVar VariationId is 2071994.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=2.36 with no splicing effect.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_198129.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LAMA3
NM_198129.4
MANE Select
c.160C>Tp.Leu54Leu
synonymous
Exon 1 of 75NP_937762.2Q16787-2
LAMA3
NM_001127717.4
c.160C>Tp.Leu54Leu
synonymous
Exon 1 of 74NP_001121189.2A0A0A0MSA0
LAMA3
NM_001302996.2
c.160C>Tp.Leu54Leu
synonymous
Exon 1 of 9NP_001289925.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LAMA3
ENST00000313654.14
TSL:1 MANE Select
c.160C>Tp.Leu54Leu
synonymous
Exon 1 of 75ENSP00000324532.8Q16787-2
LAMA3
ENST00000399516.7
TSL:1
c.160C>Tp.Leu54Leu
synonymous
Exon 1 of 74ENSP00000382432.2Q16787-3
LAMA3
ENST00000585600.5
TSL:1
n.160C>T
non_coding_transcript_exon
Exon 1 of 13ENSP00000468316.1A0A075B783

Frequencies

GnomAD3 genomes
AF:
0.000585
AC:
89
AN:
152244
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00210
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.0000742
AC:
11
AN:
148322
AF XY:
0.0000741
show subpopulations
Gnomad AFR exome
AF:
0.00175
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000364
AC:
51
AN:
1401418
Hom.:
0
Cov.:
31
AF XY:
0.0000275
AC XY:
19
AN XY:
691972
show subpopulations
African (AFR)
AF:
0.00152
AC:
47
AN:
31002
American (AMR)
AF:
0.0000799
AC:
3
AN:
37568
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25098
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35834
South Asian (SAS)
AF:
0.00
AC:
0
AN:
79256
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
47708
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5688
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1081270
Other (OTH)
AF:
0.0000172
AC:
1
AN:
57994
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.458
Heterozygous variant carriers
0
3
6
8
11
14
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000584
AC:
89
AN:
152358
Hom.:
0
Cov.:
32
AF XY:
0.000671
AC XY:
50
AN XY:
74504
show subpopulations
African (AFR)
AF:
0.00209
AC:
87
AN:
41590
American (AMR)
AF:
0.00
AC:
0
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5180
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10628
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
68026
Other (OTH)
AF:
0.000473
AC:
1
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
5
10
15
20
25
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000260
Hom.:
0
Bravo
AF:
0.000597

ClinVar

ClinVar submissions
Significance:Likely benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
LAMA3-related disorder (1)
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.29
CADD
Benign
13
DANN
Uncertain
0.98
PhyloP100
2.4
PromoterAI
0.042
Neutral

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs565693075; hg19: chr18-21269807; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.